824/2010 [2021] - Real Decreto

Article 38 (as referenced in related safety literature) requires technical directors to ensure staff receive continuous training and that safety protocols for handling hazardous drugs are implemented.

The , of June 25, is the foundational piece of Spanish legislation regulating pharmaceutical laboratories, manufacturers of active substances, and the foreign trade of medicines. By integrating multiple European directives into a single framework, it ensures that all drugs—whether for human use, veterinary use, or research—meet strict safety and quality standards. Key Objectives of the Decree real decreto 824/2010

Any feature must account for the mandatory authorization by the Spanish Agency for Medicines and Health Products (AEMPS) for any laboratory involved in manufacturing, importing, or exporting medicines. Article 38 (as referenced in related safety literature)